[1] |
Thorne I, Sutcliffe N. Sjögren′s syndrome[J]. Br J Hosp Med (Lond), 2017,78(8):438-442.
doi: 10.12968/hmed.2017.78.8.438
URL
|
[2] |
Margaretten M. Neurologic Manifestations of Primary Sjögren Syndrome[J]. Rheum Dis Clin North Am, 2017,43(4):519-529.
doi: 10.1016/j.rdc.2017.06.002
URL
|
[3] |
Moosa MY, Coovadia YM. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients[J]. Clin Infect Dis, 1997,24(2):131-134.
pmid: 9114135
|
[4] |
Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy[J]. Clin Infect Dis, 2001, 33(5):690-699.
pmid: 11477526
|
[5] |
Chau TT, Mai NH, Phu NH, et al. A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying di-sease[J]. BMC Infect Dis, 2010,10:199.
doi: 10.1186/1471-2334-10-199
URL
|
[6] |
Lee YC, Wang JT, Sun HY, et al. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection[J]. J Microbiol Immunol Infect, 201144(5):338-345.
|
[7] |
Zheng H, Chen Q, Xie Z, et al. A retrospective research of HIV-negative cryptococcal meningoencephalitis patients with acute/subacute onset[J]. Eur J Clin Microbiol Infect Dis, 2016,35(2):299-303.
doi: 10.1007/s10096-015-2545-0
URL
|
[8] |
Li M, Chen Z, Xu L, et al. A Comparison of the clinical characteristics and outcomes of cryptococcal meningitis in HIV-negative individuals with and without immunosuppression[J]. Neurologist, 2019,24(1):1-5.
doi: 10.1097/NRL.0000000000000221
URL
|
[9] |
Marr KA, Sun Y, Spec A, et al. A multicenter, longitu-dinal cohort study of cryptococcosis in human immuno-deficiency virus-negative people in the United States[J]. Clin Infect Dis, 2020,70(2):252-261.
doi: 10.1093/cid/ciz193
URL
|
[10] |
常艳宇, 胡学强. 新型隐球菌性脑膜炎和(或)脑炎102例诊断与治疗经验[J]. 中国现代神经疾病杂志, 2014,14(8):687-692.
|
[11] |
Beardsley J, Hoang NLT, Kibengo FM, et al. Do intrace-rebral cytokine responses explain the harmful effects of dexamethasone in human immunodeficiency virus-associated cryptococcal meningitis?[J]. Clin Infect Dis, 2019,68(9):1494-1501.
doi: 10.1093/cid/ciy725
pmid: 30169607
|
[12] |
Boulware DR, Rolfes MA, Rajasingham R, et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast[J]. Emerg Infect Dis, 2014,20(1):45-53.
doi: 10.3201/eid2001.130906
pmid: 24378231
|
[13] |
Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america[J]. Clin Infect Dis, 2010,50(3):291-322.
doi: 10.1086/649858
pmid: 20047480
|
[14] |
刘正印, 王贵强, 朱利平, 等. 隐球菌性脑膜炎诊治专家共识[J]. 中华内科杂志, 2018,57(5):317-323.
|
[15] |
Tseng HK, Liu CP, Ho MW, et al. Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010[J]. PLoS One,2013, 8(4):e61921.
doi: 10.1371/journal.pone.0061921
URL
|
[16] |
Pappas PG. Cryptococcal infections in non-HIV-infected patients[J]. Trans Am Clin Climatol Assoc, 2013,124:61-79.
pmid: 23874010
|
[17] |
Fang W, Chen M, Liu J, et al. Cryptococcal meningitis in systemic lupus erythematosus patients: pooled analysis and systematic review[J]. Emerg Microbes Infect, 2016, 5(9):e95.
|
[18] |
Dixon WG, Abrahamowicz M, Beauchamp ME, et al. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis[J]. Ann Rheum Dis, 2012,71(7):1128-1133.
doi: 10.1136/annrheumdis-2011-200702
URL
|
[19] |
Liao TL, Chen YM, Chen DY. Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications[J]. Clin Microbiol Infect, 2016,22(9):815,e1.
|